NYSE:LCTX | Cash Flow Statement | Lineage Cell Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$1.48M
2026-03-31-$4.81M-$8.08M$55,000.00-$2.33M$5.56M
2025-12-31$851,000.00-$4.88M$399,000.00-$15.33M$20.38M
2025-09-30-$29.78M
2025-06-30-$30.46M
2025-03-31-$4.14M-$4.89M$97,000.00$1.9M$5.04M
2024-12-31-$3.27M-$6.35M$365,000.00$2.64M$21.73M
2024-09-30-$3.03M
2024-06-30-$5.76M
2024-03-31-$6.54M-$5.78M$38,000.00-$38,000.00$14.02M
2023-12-31-$4.78M-$6.02M$91,000.00$9.74M-$13,000.00
2023-09-30-$7.11M
2023-06-30-$5.23M
2023-03-31-$4.37M$138,000.00-$11.24M$188,000.00$15.43M$1,000.00
2022-12-31-$6.35M$141,000.00-$8.3M-$16,000.00-$5.1M$122,000.00
2022-09-30-$6.07M
2022-06-30-$6.76M
2022-03-31-$7.09M$150,000.00$21.9M$46,000.00-$46,000.00$513,000.00
2021-12-31-$28.99M$159,000.00-$5.87M$146,000.00-$146,000.00$954,000.00
2021-09-30-$7.82M
2021-06-30-$4.79M
2021-03-31-$1.42M$174,000.00-$7.42M$11,000.00$10.07M$20.96M
2020-12-31$2.03M$200,000.00-$5.64M$24,000.00$902,000.00$4.81M
2020-09-30-$7.76M$200,000.00
2020-06-30-$6.52M$210,000.00
2020-03-31-$8.4M$212,000.00-$5.03M$10,000.00$5.26M-$10,000.00
2019-12-31-$4.48M$236,000.00-$5.52M$7,000.00$720,000.00-$5,000.00
2019-09-30-$16.51M$253,000.00
2019-06-30-$30.03M$244,000.00
2019-03-31$39.31M$269,000.00-$9.31M$169,000.00$2.95M$606,000.00
2018-12-31-$44.95M$267,000.00-$5.81M$157,000.00$9.78M$94,000.00
2018-09-30$66.73M$254,000.00
2018-06-30-$4.22M$279,000.00
2018-03-31-$63.55M$281,000.00-$10.34M$198,000.00$2.21M$633,000.00
2017-12-31-$71.93M$277,000.00-$5.68M$396,000.00-$583,000.00$26.38M
2017-09-30$14.32M$249,000.00
2017-06-30-$11.65M$205,000.00
2017-03-31$49.29M$216,000.00-$8.1M$215,000.00-$9.15M$19.1M
2016-12-31-$5.08M$184,000.00-$8.85M-$409,000.00$843,000.00
2016-09-30$31.2M
2016-06-30$24.55M
2016-03-31-$17.11M$429,000.00-$14.31M$583,000.00
2015-12-31-$13.42M-$13.95M$727,000.00
2015-09-30-$13.63M
2015-06-30-$9.69M
2015-03-31-$10.17M-$9.07M$77,000.00
2014-12-31-$10.58M-$9.11M-$14,000.00
2014-09-30-$8.27M
2014-06-30-$9.52M
2014-03-31-$8.1M-$10.36M$231,921.00-$527,618.00$12.13M
2013-12-31-$19.61M-$8.63M$300,958.00-$1.66M$9.13M
2013-09-30-$9M
2013-06-30-$7.55M
2013-03-31-$7.72M-$7.02M$496,128.00-$550,551.00$13.11M
2012-12-31-$6.03M-$5M$195,675.00-$195,910.00$1.63M
2012-09-30-$4.96M
2012-06-30-$5.46M
2012-03-31-$4.97M-$5.72M$116,603.00-$117,129.00$0.00
2011-12-31-$5.36M-$3.85M$179,757.00-$179,997.00$733.00
2011-09-30-$3.74M
2011-06-30-$4.28M
2011-03-31-$3.36M-$3.36M$295,785.00-$537,983.00$689,831.00
2010-12-31-$2.97M-$2.78M$54,324.00$3.9M$7.09M
2010-09-30-$4.67M
2010-06-30-$2.26M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$63.53M-$18.92M$522,000.00-$13.46M$26.95M
2024-12-31-$18.61M-$23.09M$565,000.00-$2.31M$35.86M
2023-12-31-$21.49M-$28.57M$674,000.00$46.45M$6.42M
2022-12-31-$26.27M$582,000.00$1.06M$413,000.00-$46.16M$1.63M
2021-12-31-$43.02M$663,000.00-$23.56M$340,000.00$9.75M$36.93M
2020-12-31-$20.65M$823,000.00-$19.75M$64,000.00$13.04M$29.87M
2019-12-31-$11.71M$1M-$31.95M$440,000.00$16.96M$617,000.00
2018-12-31-$45.99M$1.08M-$30.88M$556,000.00$11.82M$5.77M
2017-12-31-$19.98M$947,000.00-$30.52M$1.33M-$10.23M$55.39M
2016-12-31$33.57M$1.18M-$42.33M$2.25M-$10.89M$32.78M
2015-12-31-$46.99M$1.08M-$44.54M$1.24M-$7.44M$64.78M
2014-12-31-$36.41M$1.05M-$38.85M$483,000.00
2013-12-31-$43.88M-$29.51M$2.28M-$3.67M$34.26M
2012-12-31-$21.43M-$19.68M$400,810.00-$104,687.00$1.91M
2011-12-31-$16.52M-$13.59M$960,281.00-$1.2M$3.86M
2010-12-31-$11.18M-$7.73M$220,771.00$3.2M$25.77M
2009-12-31-$5.14M-$4.26M$61,276.00-$46,226.00$16.48M